{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:47:18Z","timestamp":1793756838386,"version":"4.6.1"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Health Focus Products Australia Pty. Ltd"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejmech.2020.112326","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T20:42:28Z","timestamp":1588106548000},"page":"112326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":131,"special_numbering":"C","title":["Recent advances in DNA gyrase-targeted antimicrobial agents"],"prefix":"10.1016","volume":"199","author":[{"given":"Satish N.","family":"Dighe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trudi A.","family":"Collet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112326_bib1","series-title":"How to Overcome the Antibiotic Crisis","first-page":"365","article-title":"New structural templates for clinically validated and novel targets in antimicrobial drug research and development","author":"Klahn","year":"2016"},{"key":"10.1016\/j.ejmech.2020.112326_bib2","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1016\/j.bmc.2016.04.043","article-title":"Discovery and development of kibdelomycin, a new class of broad-spectrum antibiotics targeting the clinically proven bacterial type II topoisomerase","volume":"24","author":"Singh","year":"2016","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib3","series-title":"The Bacterial Challenge: Time to React","author":"ECDC","year":"2009"},{"key":"10.1016\/j.ejmech.2020.112326_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! an update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112326_bib5","series-title":"Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics","first-page":"27","author":"Tacconelli","year":"2017"},{"key":"10.1016\/j.ejmech.2020.112326_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/M16-0291","article-title":"Progress in the fight against multidrug-resistant bacteria? A review of US Food and Drug Administration\u2013approved antibiotics, 2010\u20132015","volume":"165","author":"Deak","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejmech.2020.112326_bib7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrm831","article-title":"Cellular roles of DNA topoisomerases: a molecular perspective","volume":"3","author":"Wang","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2020.112326_bib8","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2020.112326_bib9","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1021\/cb400592n","article-title":"Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug\u2013enzyme interactions","volume":"8","author":"Aldred","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2020.112326_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","article-title":"Exploiting bacterial DNA gyrase as a drug target: current state and perspectives","volume":"92","author":"Collin","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2020.112326_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/1062936X.2017.1310131","article-title":"Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors","volume":"28","author":"Azam","year":"2017","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.ejmech.2020.112326_bib12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tibs.2013.04.006","article-title":"From keys to bulldozers: expanding roles for winged helix domains in nucleic-acid-binding proteins","volume":"38","author":"Harami","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2020.112326_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0968-0004(99)01503-0","article-title":"GHKL, an emergent ATPase\/kinase superfamily","volume":"25","author":"Dutta","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2020.112326_bib14","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1093\/nar\/26.18.4205","article-title":"Toprim\u2014a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins","volume":"26","author":"Aravind","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2020.112326_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/1568026613666131113150046","article-title":"Designing type II topoisomerase inhibitors: a molecular modeling approach","volume":"14","author":"J Perez","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bbagen.2015.12.019","article-title":"Fluoroquinolones stimulate the DNA cleavage activity of topoisomerase IV by promoting the binding of Mg2+ to the second metal binding site","volume":"1860","author":"Oppegard","year":"2016","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ejmech.2020.112326_bib17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nature08974","article-title":"A\u00a0novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases","volume":"465","author":"Schmidt","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112326_bib18","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1093\/nar\/gkr018","article-title":"Use of divalent metal ions in the DNA cleavage reaction of topoisomerase IV","volume":"39","author":"Pitts","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2020.112326_bib19","doi-asserted-by":"crossref","first-page":"13502","DOI":"10.1021\/bi9912488","article-title":"Probing the two-gate mechanism of DNA gyrase using cysteine cross-linking","volume":"38","author":"Williams","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2020.112326_bib20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/rccm.200708-1151OC","article-title":"Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis","volume":"177","author":"Tunney","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2020.112326_bib21","first-page":"181","article-title":"Effect of oxygen limitation on the in\u00a0vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients","volume":"66","author":"King","year":"2010"},{"key":"10.1016\/j.ejmech.2020.112326_bib22","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/jm01240a021","article-title":"1, 8-Naphthyridine derivatives. A new class of chemotherapeutic agents","volume":"5","author":"Lesher","year":"1962","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrmicro2333","article-title":"How antibiotics kill bacteria: from targets to networks","volume":"8","author":"Kohanski","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112326_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg212","article-title":"Development of the quinolones","volume":"51","author":"Andersson","year":"2003","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112326_bib25","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1016\/j.tet.2011.08.089","article-title":"Synthesis of naphthyridone derivatives containing 8-alkoxyimino-1, 6-dizaspiro [3.4] octane scaffolds","volume":"67","author":"Feng","year":"2011","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2020.112326_bib26","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.2174\/092986709788186156","article-title":"The 4-quinolone-3-carboxylic acid motif as a multivalent scaffold in medicinal chemistry","volume":"16","author":"Mugnaini","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib27","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.3762\/bjoc.9.265","article-title":"An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles","volume":"9","author":"Baumann","year":"2013","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib28","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1016\/j.bmc.2016.09.027","article-title":"Identification of 5, 6-dihydroimidazo [2, 1-b] thiazoles as a new class of antimicrobial agents","volume":"24","author":"Li","year":"2016","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib29","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1126\/science.6243420","article-title":"DNA gyrase and the supercoiling of DNA","volume":"207","author":"Cozzarelli","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112326_bib30","doi-asserted-by":"crossref","first-page":"a025320","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejmech.2020.112326_bib31","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112326_bib32","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nsmb.1892","article-title":"Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance","volume":"17","author":"Wohlkonig","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2020.112326_bib33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nsmb.1604","article-title":"Structural insight into the quinolone\u2013DNA cleavage complex of type IIA topoisomerases","volume":"16","author":"Laponogov","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2020.112326_bib34","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/jcla.21961","article-title":"Rapid detection of genomic mutations in gyrA and parC genes of Escherichia coli by multiplex allele specific polymerase chain reaction","volume":"30","author":"Onseedaeng","year":"2016","journal-title":"J.\u00a0Clin. Lab. Anal."},{"key":"10.1016\/j.ejmech.2020.112326_bib35","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1128\/AAC.03734-14","article-title":"Bacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridge","volume":"58","author":"Aldred","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112326_bib36","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1021\/bi501073v","article-title":"Activity of quinolone CP-115,955 against bacterial and human type II topoisomerases is mediated by different interactions","volume":"54","author":"Aldred","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2020.112326_bib37","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1128\/AAC.45.12.3517-3523.2001","article-title":"Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates ofStreptococcus pneumoniae","volume":"45","author":"Weigel","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112326_bib38","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.4155\/fmc-2016-0042","article-title":"Targeting bacterial topoisomerases: how to counter mechanisms of resistance","volume":"8","author":"Tse-Dinh","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib39","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1021\/cr4003984","article-title":"Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism","volume":"114","author":"Mayer","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2020.112326_bib40","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ejmech.2016.10.011","article-title":"Multi-targeting exploration of new 2-aminothiazolyl quinolones: synthesis, antimicrobial evaluation, interaction with DNA, combination with topoisomerase IV and penetrability into cells","volume":"124","author":"Cheng","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12010-014-1256-9","article-title":"Synthesis of 4-hydroxy-2 (1H)-quinolone derived chalcones, pyrazolines and their antimicrobial, in silico antimalarial evaluations","volume":"175","author":"Sarveswari","year":"2015","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.ejmech.2020.112326_bib42","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejmech.2018.05.021","article-title":"Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents","volume":"154","author":"Xu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib43","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.bmcl.2017.01.073","article-title":"New 1, 4-dihydro [1, 8] naphthyridine derivatives as DNA gyrase inhibitors","volume":"27","author":"Gen\u00e7er","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112326_bib44","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/AAC.01545-09","article-title":"In\u00a0vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species","volume":"54","author":"Disratthakit","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112326_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005013","article-title":"DC-159a shows inhibitory activity against DNA gyrases of Mycobacterium leprae","volume":"10","author":"Yamaguchi","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2020.112326_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/mdr.2018.0078","article-title":"Antibacterial activity of DC-159a against Salmonella typhimurium","volume":"25","author":"Koide","year":"2019","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.ejmech.2020.112326_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/22113626130109","article-title":"SAR and anti-mycobacterial activity of quinolones and triazoloquinolones: an update","volume":"11","author":"Briguglio","year":"2013","journal-title":"Anti-Infect. Agents"},{"key":"10.1016\/j.ejmech.2020.112326_bib48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejmech.2018.10.031","article-title":"Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase","volume":"161","author":"Carta","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib49","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.bmcl.2018.03.085","article-title":"Design, synthesis, and evaluation of novel N-1 fluoroquinolone derivatives: probing for binding contact with the active site tyrosine of gyrase","volume":"28","author":"Towle","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib50","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bioorg.2019.01.009","article-title":"Piperazine-azole-fluoroquinolone hybrids: conventional and microwave irradiated synthesis, biological activity screening and molecular docking studies","volume":"85","author":"Mermer","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib51","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/molecules21040268","article-title":"The current case of quinolones: synthetic approaches and antibacterial activity","volume":"21","author":"Naeem","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112326_bib52","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/slct.201800108","article-title":"Synthesis, antibacterial activity and molecular docking of substituted naphthyridines as potential DNA gyrase inhibitors","volume":"3","author":"Omar","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2020.112326_bib53","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bioorg.2018.08.031","article-title":"Synthesis, antimicrobial activity and molecular modeling study of 3-(5-amino-(2H)-1, 2, 4-triazol-3-yl]-naphthyridinones as potential DNA-gyrase inhibitors","volume":"81","author":"Mohamed","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00044-017-1970-2","article-title":"Synthesis of new 7-chloro-4-phenoxyquinoline analogues as potential antitubercular agents","volume":"27","author":"Salve","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112326_bib55","doi-asserted-by":"crossref","first-page":"10945","DOI":"10.1021\/jacs.6b04831","article-title":"Dual targeting of intracellular pathogenic bacteria with a cleavable conjugate of kanamycin and an antibacterial cell-penetrating peptide","volume":"138","author":"Brezden","year":"2016","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112326_bib56","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1021\/acschembio.7b00540","article-title":"Enhancing the potency of nalidixic acid toward a bacterial DNA gyrase with conjugated peptides","volume":"12","author":"Ahmed","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2020.112326_bib57","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.bmc.2017.02.068","article-title":"Covalently linked kanamycin\u2013Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance","volume":"25","author":"Shavit","year":"2017","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700029","article-title":"Synthesis and evaluation of thiazolidine amide and N-thiazolyl amide fluoroquinolone derivatives","volume":"350","author":"Garza","year":"2017","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2020.112326_bib59","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/cbdd.12532","article-title":"Design, synthesis, and antimicrobial evaluation of novel quinolone imidazoles and interactions with MRSA DNA","volume":"86","author":"Zhang","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2020.112326_bib60","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1039\/C5MD00186B","article-title":"Design, synthesis, and antibacterial evaluation of novel azolylthioether quinolones as MRSA DNA intercalators","volume":"6","author":"Zhang","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2020.112326_bib61","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1021\/acs.jmedchem.5b01678","article-title":"Novel 3-aminothiazolquinolones: design, synthesis, bioactive evaluation, SARs, and preliminary antibacterial mechanism","volume":"59","author":"Cui","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib62","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1002\/anie.201209979","article-title":"Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials","volume":"52","author":"O\u2019Connell","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2020.112326_bib63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejmech.2019.01.072","article-title":"Design and synthesis of aminothiazolyl norfloxacin analogues as potential antimicrobial agents and their biological evaluation","volume":"167","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib64","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/j.bmcl.2015.07.010","article-title":"Synthesis of ciprofloxacin dimers for evaluation of bacterial permeability in atypical chemical space","volume":"25","author":"Ross","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib65","doi-asserted-by":"crossref","first-page":"64460","DOI":"10.1039\/C6RA09891F","article-title":"Synthesis of quinoline acetohydrazide-hydrazone derivatives evaluated as DNA gyrase inhibitors and potent antimicrobial agents","volume":"6","author":"Sridhar","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2020.112326_bib66","doi-asserted-by":"crossref","first-page":"e02100","DOI":"10.1128\/AAC.02100-16","article-title":"Novel bacterial topoisomerase inhibitors with potent broad-spectrum activity against drug-resistant bacteria","volume":"61","author":"Charrier","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112326_bib67","doi-asserted-by":"crossref","first-page":"7483","DOI":"10.1016\/j.bmcl.2011.09.114","article-title":"Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases","volume":"21","author":"Miles","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib68","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1021\/jm300690s","article-title":"Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced p K a: antibacterial agents with an improved safety profile","volume":"55","author":"Reck","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib69","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.bmcl.2013.03.047","article-title":"Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV","volume":"23","author":"Mitton-Fry","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib70","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.bmcl.2015.03.044","article-title":"Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2)","volume":"25","author":"Singh","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib71","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1021\/acsinfecdis.8b00035","article-title":"Mechanism of action of Mycobacterium tuberculosis gyrase inhibitors: a novel class of gyrase poisons","volume":"4","author":"Gibson","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112326_bib72","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.bmcl.2015.04.063","article-title":"Hydroxy tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of RHS moiety (Part-3)","volume":"25","author":"Singh","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib73","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.bmcl.2015.04.002","article-title":"Structure activity relationship of substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-4)","volume":"25","author":"Singh","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib74","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1016\/j.bmcl.2015.06.061","article-title":"Structure activity relationship of C-2 ether substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-5)","volume":"25","author":"Singh","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib75","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1016\/j.bmcl.2015.06.057","article-title":"Structure activity relationship of pyridoxazinone substituted RHS analogs of oxabicyclooctane-linked 1,5-naphthyridinyl novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-6)","volume":"25","author":"Singh","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib76","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1039\/C5MD00297D","article-title":"C1\u2013C2-linker substituted 1, 5-naphthyridine analogues of oxabicyclooctane-linked NBTIs as broad-spectrum antibacterial agents (part 7)","volume":"6","author":"Singh","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2020.112326_bib77","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ejmech.2014.08.018","article-title":"Extending the N-linked aminopiperidine class to the mycobacterial gyrase domain: pharmacophore mapping from known antibacterial leads","volume":"85","author":"Bobesh","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib78","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1021\/ml5001728","article-title":"Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing","volume":"5","author":"Hameed P","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112326_bib79","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bmc.2015.11.039","article-title":"Replacement of cardiotoxic aminopiperidine linker with piperazine moiety reduces cardiotoxicity? Mycobacterium tuberculosis novel bacterial topoisomerase inhibitors","volume":"24","author":"Bobesh","year":"2016","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib80","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.bmcl.2017.06.009","article-title":"Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV","volume":"27","author":"Mitton-Fry","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112326_bib81","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1021\/jm400963y","article-title":"Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity","volume":"56","author":"Surivet","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib82","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1021\/jm501590q","article-title":"Novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram positive activity and improved safety profile","volume":"58","author":"Surivet","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/dkg208","article-title":"The quinolones: decades of development and use","volume":"51","author":"Emmerson","year":"2003","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112326_bib84","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1021\/bi0159837","article-title":"DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5 \u2018-methyl group of the Noviose","volume":"41","author":"Lafitte","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2020.112326_bib85","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1021\/bi970294+","article-title":"The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study","volume":"36","author":"Holdgate","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2020.112326_bib86","first-page":"41","article-title":"The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin, Proteins: structure, Function","volume":"28","author":"Tsai","year":"1997","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2020.112326_bib87","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/j.1460-2075.1996.tb00483.x","article-title":"The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography","volume":"15","author":"Lewis","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2020.112326_bib88","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2174\/092986707781368414","article-title":"Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents","volume":"14","author":"Oblak","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib89","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1021\/acs.jmedchem.5b00775","article-title":"N-Phenyl-4, 5-dibromopyrrolamides and N-phenylindolamides as ATP competitive DNA gyrase B inhibitors: design, synthesis, and evaluation","volume":"58","author":"Zidar","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib90","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejmech.2016.06.042","article-title":"Engineering another class of anti-tubercular lead: hit to lead optimization of an intriguing class of gyrase ATPase inhibitors","volume":"122","author":"Jeankumar","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib91","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/cb300510w","article-title":"Aminopyrazinamides: novel and specific GyrB inhibitors that kill replicating and nonreplicating Mycobacterium tuberculosis","volume":"8","author":"Shirude","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2020.112326_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.06.032","article-title":"4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: structural optimization, synthesis and biological evaluation","volume":"103","author":"Medapi","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib93","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.bmc.2015.03.004","article-title":"Design and synthesis of novel quinoline\u2013aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors","volume":"23","author":"Medapi","year":"2015","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib94","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejmech.2016.03.079","article-title":"New N-phenyl-4, 5-dibromopyrrolamides and N-Phenylindolamides as ATPase inhibitors of DNA gyrase","volume":"117","author":"Zidar","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib95","doi-asserted-by":"crossref","first-page":"8941","DOI":"10.1021\/acs.jmedchem.6b00864","article-title":"Discovery of benzothiazole scaffold-based DNA gyrase B inhibitors","volume":"59","author":"Gjorgjieva","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib96","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bmc.2016.10.038","article-title":"Design, synthesis and biological evaluation of 4, 5-dibromo-N-(thiazol-2-yl)-1H-pyrrole-2-carboxamide derivatives as novel DNA gyrase inhibitors","volume":"25","author":"Toma\u0161i\u010d","year":"2017","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib97","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/cmdc.201700549","article-title":"Synthesis and evaluation of N-phenylpyrrolamides as DNA gyrase B inhibitors","volume":"13","author":"Durcik","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2020.112326_bib98","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejmech.2018.05.011","article-title":"New N-phenylpyrrolamide DNA gyrase B inhibitors: optimization of efficacy and antibacterial activity","volume":"154","author":"Durcik","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib99","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejmech.2019.02.004","article-title":"An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors","volume":"167","author":"Tiz","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib100","doi-asserted-by":"crossref","first-page":"1700087","DOI":"10.1002\/ardp.201700087","article-title":"Design, synthesis, and evaluation of novel tyrosine-based DNA gyrase B inhibitors","volume":"350","author":"Cotman","year":"2017","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2020.112326_bib101","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1016\/j.bmcl.2011.10.010","article-title":"Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy","volume":"21","author":"Sherer","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib102","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejmech.2017.02.046","article-title":"Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors","volume":"130","author":"Jakopin","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib103","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejmech.2016.09.040","article-title":"Linker-switch approach towards new ATP binding site inhibitors of DNA gyrase B","volume":"125","author":"Juki\u010d","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib104","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1021\/jm500462x","article-title":"Optimization of pyrrolamide topoisomerase II inhibitors toward identification of an antibacterial clinical candidate (AZD5099)","volume":"57","author":"Basarab","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib105","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1021\/acs.jmedchem.5b00489","article-title":"Discovery of 4, 5, 6, 7-tetrahydrobenzo [1, 2-d] thiazoles as novel DNA gyrase inhibitors targeting the ATP-binding site","volume":"58","author":"Toma\u0161i\u010d","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib106","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2174\/1573406410666140902110452","article-title":"Design, synthesis and biological evaluation of some new coumarin derivatives as potential antimicrobial agents","volume":"11","author":"Kumar Singh","year":"2015","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib107","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1016\/j.bmc.2018.05.016","article-title":"Drug efficacy of novel 3-O-methoxy-4-halo disubstituted 5, 7-dimethoxy chromans; evaluated via DNA gyrase inhibition, bacterial cell wall lesion and antibacterial prospective","volume":"26","author":"Ponnusamy","year":"2018","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib108","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bioorg.2017.01.019","article-title":"Synthesis, antimicrobial, cytotoxic and E. coli DNA gyrase inhibitory activities of coumarinyl amino alcohols","volume":"71","author":"Singh","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib109","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejmech.2018.07.059","article-title":"Novel coumarin-pyrazole carboxamide derivatives as potential topoisomerase II inhibitors: design, synthesis and antibacterial activity","volume":"157","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib110","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1039\/C6MD00229C","article-title":"A\u00a0natural product inspired fragment-based approach towards the development of novel anti-bacterial agents","volume":"7","author":"Austin","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2020.112326_bib111","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejmech.2015.10.019","article-title":"A\u00a0click chemistry approach for the synthesis of mono and bis aryloxy linked coumarinyl triazoles as anti-tubercular agents","volume":"105","author":"Anand","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib112","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bmcl.2010.12.059","article-title":"Synthesis and evaluation of a class of new coumarin triazole derivatives as potential antimicrobial agents","volume":"21","author":"Shi","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib113","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejmech.2018.02.067","article-title":"Synthesis and antimycobacterial activity of 1-(\u03b2-d-Ribofuranosyl)-4-coumarinyloxymethyl-\/-coumarinyl-1, 2, 3-triazole","volume":"150","author":"Srivastava","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib114","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1021\/jm300395d","article-title":"Structure-based discovery of substituted 4, 5\u2032-bithiazoles as novel DNA gyrase inhibitors","volume":"55","author":"Brvar","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib115","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biochi.2006.12.005","article-title":"The action of the bacterial toxin, microcin B17, on DNA gyrase","volume":"89","author":"Parks","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2020.112326_bib116","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1021\/jm030394f","article-title":"Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives","volume":"47","author":"Tanitame","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib117","doi-asserted-by":"crossref","first-page":"E4492","DOI":"10.1073\/pnas.1700721114","article-title":"Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase","volume":"114","author":"Chan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2020.112326_bib118","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.bmcl.2019.03.029","article-title":"Structure-guided design of antibacterials that allosterically inhibit DNA gyrase","volume":"29","author":"Thalji","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib119","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3390\/molecules24071311","article-title":"Discovery of novel triazole-containing pyrazole ester derivatives as potential antibacterial agents","volume":"24","author":"Chu","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112326_bib120","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1016\/j.bmcl.2013.10.058","article-title":"Design, synthesis and biological evaluation of \u03b1-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors","volume":"23","author":"Axford","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib121","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1016\/j.bmcl.2014.07.037","article-title":"Discovery and in\u00a0vivo evaluation of alcohol-containing benzothiazoles as potent dual-targeting bacterial DNA supercoiling inhibitors","volume":"24","author":"Palmer","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib122","doi-asserted-by":"crossref","first-page":"1700333","DOI":"10.1002\/ardp.201700333","article-title":"Design, synthesis, and biological evaluation of 1-ethyl-3-(thiazol-2-yl) urea derivatives as Escherichia coli DNA gyrase inhibitors","volume":"351","author":"Toma\u0161i\u010d","year":"2018","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2020.112326_bib123","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/j.bmcl.2018.05.049","article-title":"Design, synthesis and antibacterial properties of pyrimido [4, 5-b] indol-8-amine inhibitors of DNA gyrase","volume":"28","author":"McGarry","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112326_bib124","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1128\/AAC.00259-11","article-title":"Spread of ISCR1 elements containing blaDHA-1 and multiple antimicrobial resistance genes leading to increase of flomoxef resistance in extended-spectrum-\u03b2-lactamase-producing Klebsiella pneumoniae","volume":"55","author":"Lee","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112326_bib125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cbi.2008.03.003","article-title":"Interaction of \u03b2-lactam antibiotics with the mitochondrial carnitine\/acylcarnitine transporter","volume":"173","author":"Pochini","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2020.112326_bib126","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ejmech.2018.07.041","article-title":"Design and synthesis of novel 1H-tetrazol-5-amine based potent antimicrobial agents: DNA topoisomerase IV and gyrase affinity evaluation supported by molecular docking studies","volume":"156","author":"Szulczyk","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib127","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1021\/acsmedchemlett.7b00514","article-title":"Potential antimicrobial isopropanol-conjugated carbazole azoles as dual targeting inhibitors of Enterococcus faecalis","volume":"9","author":"Zhang","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112326_bib128","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.bmcl.2016.01.009","article-title":"Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB","volume":"26","author":"Mesleh","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib129","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.bmc.2014.12.001","article-title":"Exploring the gyrase ATPase domain for tailoring newer anti-tubercular drugs: hit to lead optimization of a novel class of thiazole inhibitors","volume":"23","author":"Jeankumar","year":"2015","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib130","doi-asserted-by":"crossref","first-page":"8503","DOI":"10.1021\/acs.jmedchem.5b00961","article-title":"Discovery of azaindole ureas as a novel class of bacterial gyrase B inhibitors","volume":"58","author":"Zhang","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib131","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1568026613666131113153251","article-title":"Prospects for developing new antibacterials targeting bacterial type IIA topoisomerases","volume":"14","author":"Toma\u0161i\u0107","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib132","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1021\/acsmedchemlett.5b00266","article-title":"Discovery of indazole derivatives as a novel class of bacterial gyrase B inhibitors","volume":"6","author":"Zhang","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112326_bib133","doi-asserted-by":"crossref","first-page":"8792","DOI":"10.1021\/jm500563g","article-title":"Second-generation antibacterial benzimidazole ureas: discovery of a preclinical candidate with reduced metabolic liability","volume":"57","author":"Grillot","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib134","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1021\/acsmedchemlett.5b00196","article-title":"Discovery and characterization of a water-soluble prodrug of a dual inhibitor of bacterial DNA gyrase and topoisomerase IV","volume":"6","author":"O\u2019Dowd","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112326_bib135","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1128\/AAC.00247-08","article-title":"Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors","volume":"52","author":"Miller","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112326_bib136","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1021\/jm501174m","article-title":"Novel DNA gyrase inhibiting spiropyrimidinetriones with a benzisoxazole scaffold: SAR and in\u00a0vivo characterization","volume":"57","author":"Basarab","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib137","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1021\/acs.jmedchem.5b00863","article-title":"Discovery of novel DNA gyrase inhibiting spiropyrimidinetriones: benzisoxazole fusion with N-linked oxazolidinone substituents leading to a clinical candidate (ETX0914)","volume":"58","author":"Basarab","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib138","doi-asserted-by":"crossref","first-page":"11827","DOI":"10.1038\/srep11827","article-title":"Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases","volume":"5","author":"Basarab","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112326_bib139","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/acs.jmedchem.8b01750","article-title":"Design, synthesis, and biological evaluation of novel DNA gyrase-inhibiting spiropyrimidinetriones as potent antibiotics for treatment of infections caused by multidrug-resistant gram-positive bacteria","volume":"62","author":"Shi","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tube.2018.08.005","article-title":"In silico designing of domain B selective gyrase inhibitors for effective treatment of resistant tuberculosis","volume":"112","author":"Kashyap","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2020.112326_bib141","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.3390\/molecules23102554","article-title":"Synthesis and biological evaluation of novel indole-derived thioureas","volume":"23","author":"Sanna","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112326_bib142","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/jac\/dks127","article-title":"Antistaphylococcal activity of DNA-interactive pyrrolobenzodiazepine (PBD) dimers and PBD-biaryl conjugates","volume":"67","author":"Rahman","year":"2012","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112326_bib143","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/acsinfecdis.7b00130","article-title":"C8-linked pyrrolobenzodiazepine monomers with inverted building blocks show selective activity against multidrug resistant Gram-positive bacteria","volume":"4","author":"Andriollo","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112326_bib144","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.pharep.2017.01.028","article-title":"N-Heterocyclic choline analogues based on 1, 2, 3, 4-tetrahydro (iso) quinoline scaffold with anticancer and anti-infective dual action","volume":"69","author":"Zablotskaya","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2020.112326_bib145","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.bmc.2016.01.011","article-title":"Development of acridine derivatives as selective Mycobacterium tuberculosis DNA gyrase inhibitors","volume":"24","author":"Medapi","year":"2016","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib146","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/anie.201409584","article-title":"Total synthesis of albicidin: a lead structure from Xanthomonas albilineans for potent antibacterial gyrase inhibitors","volume":"54","author":"Kretz","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2020.112326_bib147","doi-asserted-by":"crossref","first-page":"14605","DOI":"10.1002\/anie.201409964","article-title":"Cystobactamids: myxobacterial topoisomerase inhibitors exhibiting potent antibacterial activity","volume":"53","author":"Baumann","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2020.112326_bib148","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/cmdc.201600163","article-title":"Synthesis and antimicrobial activity of albicidin derivatives with variations of the central cyanoalanine building block","volume":"11","author":"Gr\u00e4tz","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2020.112326_bib149","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/cmdc.201600231","article-title":"Synthesis of albicidin derivatives: assessing the role of N-terminal acylation on the antibacterial activity","volume":"11","author":"Kerwat","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2020.112326_bib150","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/emmm.201303575","article-title":"Towards a new combination therapy for tuberculosis with next generation benzothiazinones","volume":"6","author":"Makarov","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejmech.2020.112326_bib151","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.bmcl.2013.06.069","article-title":"Synthesis and structure\u2013activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents","volume":"23","author":"Gao","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib152","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijmyco.2015.02.002","article-title":"Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors","volume":"4","author":"Chandran","year":"2015","journal-title":"Int. J. Mycobacteriol."},{"key":"10.1016\/j.ejmech.2020.112326_bib153","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1248\/cpb.56.162","article-title":"Synthesis and anti-bacterial properties of mono-carbonyl analogues of curcumin","volume":"56","author":"Liang","year":"2008","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2020.112326_bib154","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.bmc.2008.10.044","article-title":"Exploration and synthesis of curcumin analogues with improved structural stability both in\u00a0vitro and in\u00a0vivo as cytotoxic agents","volume":"17","author":"Liang","year":"2009","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112326_bib155","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1016\/j.bmcl.2015.10.022","article-title":"Chemical conjugation of 2-hexadecynoic acid to C5-curcumin enhances its antibacterial activity against multi-drug resistant bacteria","volume":"25","author":"Sanabria-Rios","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib156","doi-asserted-by":"crossref","first-page":"105600","DOI":"10.1039\/C5RA22568J","article-title":"Discovering new DNA gyrase inhibitors using machine learning approaches","volume":"5","author":"Li","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2020.112326_bib157","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/cbdd.12529","article-title":"Design and biological evaluation of furan\/pyrrole\/thiophene-2-carboxamide derivatives as efficient DNA GyraseB inhibitors of Staphylococcus aureus","volume":"86","author":"Janupally","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2020.112326_bib158","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.bmcl.2017.02.031","article-title":"Three-component, one-pot synthesis of anthranilamide Schiff bases bearing 4-aminoquinoline moiety as Mycobacterium tuberculosis gyrase inhibitors","volume":"27","author":"Salve","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112326_bib159","series-title":"The Pew Charitable Trusts","article-title":"Antibiotics currently in global clinical development","year":"2019"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420302956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420302956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:12:43Z","timestamp":1759327963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420302956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":159,"alternative-id":["S0223523420302956"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112326","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in DNA gyrase-targeted antimicrobial agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112326"}}